/CNW/ -- Healthcare is undergoing a transformative shift, with new technologies enabling breakthroughs that were once unimaginable. According to the World...
Medtech giant Stryker has outperformed the broader market over the past year, and analysts remain moderately bullish on the stock’s prospects.
Stryker is set to release its Q3 earnings next week, and analysts forecast a lower-double-digit rise in profits.
Smith & Nephew SNATSÂ SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions,...
Stryker has acquired several firms over the last few months, including one related to AI. Do these purchases make the stock a buy?
Stryker Corporation SYK has witnessed substantial gains in the year-to-date period. Shares of the company have rallied 18.6% compared with 13.4% growth of the industry. The S&P 500 Composite has risen...
Stryker Corporation SYK is well-poised for growth, backed by a robust robotic arm-assisted surgery platform, Mako, and a diversified product portfolio. An improvement in price also buoys optimism.Shares...